PRESS RELEASE published on 06/04/2024 at 08:00, 5 months 18 days ago Valbiotis reaches an agreement to terminate its licensing and supply agreement with Nestlé Health Science Valbiotis terminates licensing and supply agreement with Nestlé Health Science, securing full ownership of TOTUM•63 for diabetes treatment. Strategic control and future partnerships planned Licensing Agreement Valbiotis Diabetes Treatment TOTUM•63 Nestlé Health Science
BRIEF published on 05/24/2024 at 17:45, 5 months 28 days ago VALBIOTIS : Information mensuelle sur les droits de vote et actions au 17 mai 2024 Droits De Vote Euronext Capital Social Actions Valbiotis
BRIEF published on 05/24/2024 at 17:45, 5 months 28 days ago VALBIOTIS: Monthly information on voting rights and shares as of May 17, 2024 Share Capital Voting Rights Euronext Actions Valbiotis
PRESS RELEASE published on 05/24/2024 at 17:40, 5 months 28 days ago Valbiotis : Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social - 17 mai 2024 Valbiotis : Information mensuelle sur le nombre total de droits de vote et d'actions - 17 mai 2024. Valbiotis communique le nombre d'actions et de droits de vote, conformément aux obligations réglementaires de l'Autorité des Marchés Financiers Autorité Des Marchés Financiers Droits De Vote Capital Social Informations Mensuelles Valbiotis
BRIEF published on 05/22/2024 at 17:45, 5 months 30 days ago Valbiotis lance son site de e-commerce pour Valbiotis®PRO Cholestérol E-commerce Valbiotis Compléments Alimentaires Hypercholestérolémie Lipidrive
BRIEF published on 05/22/2024 at 17:45, 5 months 30 days ago Valbiotis launches its e-commerce site for Valbiotis®PRO Cholesterol E-commerce Valbiotis Lipidrive Hypercholesterolemia Food Supplements
PRESS RELEASE published on 05/22/2024 at 17:40, 5 months 30 days ago Valbiotis lance son site de e-commerce pour la commercialisation de Valbiotis®PRO Cholestérol Valbiotis lance son site de e-commerce pour la commercialisation de Valbiotis®PRO Cholestérol. La société annonce l'ouverture de son site marchand pour rendre ses produits innovants accessibles à tous E-commerce Valbiotis Compléments Alimentaires Prevention Valbiotis®PRO Cholestérol
PRESS RELEASE published on 05/22/2024 at 17:40, 5 months 30 days ago Valbiotis launches its e-commerce site for the marketing of Valbiotis®PRO Cholestérol Valbiotis launches its e-commerce site for the marketing of Valbiotis®PRO Cholestérol on schedule, making innovative products accessible to all, including the Valbiotis®PLUS range of natural dietary supplements Digital Marketing Valbiotis Dietary Supplements Valbiotis®PRO Cholestérol E-commerce Site
BRIEF published on 05/14/2024 at 08:35, 6 months 8 days ago Valbiotis publie ses chiffres de droits de vote pour avril 2024 Droits De Vote Capital Social Actions Euronext Growth Valbiotis
BRIEF published on 05/14/2024 at 08:35, 6 months 8 days ago Valbiotis publishes its voting rights figures for April 2024 Share Capital Voting Rights Actions Euronext Growth Valbiotis
Published on 11/22/2024 at 09:00, 3 hours 27 minutes ago Industrial Software Company mlean Celebrates 10 Years of Continuous Improvement
Published on 11/22/2024 at 00:00, 12 hours 27 minutes ago Gratomic Announces Company and Operational Update
Published on 11/21/2024 at 22:05, 14 hours 22 minutes ago Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate
Published on 11/21/2024 at 21:50, 14 hours 37 minutes ago Seventy Ninth Resources Announces Successful First Reconnaissance at McKellar Copper-Zinc and Enable Gold Projects
Published on 11/21/2024 at 20:15, 16 hours 12 minutes ago Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals
Published on 11/22/2024 at 11:54, 33 minutes ago PIERER Mobility denies media reports about Mark Mateschitz's participation in PIERER Mobility and KTM
Published on 11/22/2024 at 11:45, 42 minutes ago How 5G Transforms Life: A Foreigner's Journey Through East China's Digital Revolution
Published on 11/22/2024 at 11:21, 1 hour 6 minutes ago Original-Research: ParTec AG (von First Berlin Equity Research GmbH): Buy
Published on 11/22/2024 at 11:06, 1 hour 21 minutes ago Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): BUY
Published on 11/21/2024 at 06:58, 1 day 5 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 1 day 5 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 1 day 5 hours ago Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 1 day 16 hours ago Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 1 day 17 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting